These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2846217)

  • 1. Demonstration in vitro of cell mediated immunity to Epstein-Barr virus in cotton-top tamarins.
    Finerty S; Scullion FT; Morgan AJ
    Clin Exp Immunol; 1988 Aug; 73(2):181-5. PubMed ID: 2846217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.
    Epstein MA; Randle BJ; Finerty S; Kirkwood JK
    Clin Exp Immunol; 1986 Mar; 63(3):485-90. PubMed ID: 3011324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use.
    Morgan AJ; Allison AC; Finerty S; Scullion FT; Byars NE; Epstein MA
    J Med Virol; 1989 Sep; 29(1):74-8. PubMed ID: 2555448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
    Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
    J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of cell-mediated immunity to Epstein Barr virus.
    Shooshtari MM; Dehkordi MB; Sharifi Z
    Iran J Allergy Asthma Immunol; 2005 Sep; 4(3):125-8. PubMed ID: 17301434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
    Mori T; Koishi T; Fujii G; Ohsawa N
    Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.
    Tiebout RF; Sauerwein RW; van der Meer WG; van Boxtel-Oosterhof F; Zeijlemaker WP
    Immunology; 1987 Feb; 60(2):187-93. PubMed ID: 3028938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to Epstein-Barr virus in atomic bomb survivors: study of precursor frequency of cytotoxic lymphocytes and titer levels of anti-Epstein-Barr virus-related antibodies.
    Kusunoki Y; Kyoizumi S; Fukuda Y; Huang H; Saito M; Ozaki K; Hirai Y; Akiyama M
    Radiat Res; 1994 Apr; 138(1):127-32. PubMed ID: 8146292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell memory: lessons from Epstein-Barr virus infection in man.
    Rickinson AB; Callan MF; Annels NE
    Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):391-400. PubMed ID: 10794060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
    Felton SC; Hoffmann CC; Kreier JP; Glaser R
    Lab Anim Sci; 1984 Apr; 34(2):164-8. PubMed ID: 6328114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
    Katsuki T; Katsuki K; Imai J; Hinuma Y
    Jpn J Cancer Res; 1987 Jul; 78(7):639-42. PubMed ID: 3040648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant AAV-LMP-induced LMP specific cytotoxic response to autologous lymphoblastoid cell lines tranformed by Epstein-Barr virus].
    Zhao F; Liu H; Zhou L; Cai W; Du B; Ye S; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):247-51. PubMed ID: 15617340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.
    Ando I; Morgan G; Levinsky RJ; Crawford DH
    Clin Exp Immunol; 1986 Feb; 63(2):271-9. PubMed ID: 3009060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses.
    Miller G; Shope T; Coope D; Waters L; Pagano J; Bornkamn G; Henle W
    J Exp Med; 1977 Apr; 145(4):948-67. PubMed ID: 192829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporin A on immunoglobulin production by EB virus stimulated lymphocytes.
    Pereira RS; Gear AJ; Doré CJ; Webster AD
    Clin Exp Immunol; 1983 Jul; 53(1):115-21. PubMed ID: 6307560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.